(Q78411240)
Statements
Phase II study of dolastatin-10 as first-line treatment for advanced colorectal cancer (English)
James L Abbruzzese
Everardo D Saad
Eric H Kraut
Paulo M Hoff
Dennis F Moore
Donnah Jones
scientific article published on 01 October 2002